BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Marinaki S, Boletis JN, Sakellariou S, Delladetsima IK. Hepatitis C in hemodialysis patients. World J Hepatol 2015; 7(3): 548-558 [PMID: 25848478 DOI: 10.4254/wjh.v7.i3.548]
URL: https://www.wjgnet.com/1948-5182/full/v7/i3/548.htm
Number Citing Articles
1
Manoochehr Makvandi. Update on occult hepatitis B virus infectionWorld Journal of Gastroenterology 2016; 22(39): 8720-8734 doi: 10.3748/wjg.v22.i39.8720
2
Elizabeth Buganza-Torio, Karen Elizabeth Doucette. Management of Viral Hepatitis in Solid Organ Transplant RecipientsInfectious Disease Clinics of North America 2018; 32(3): 635 doi: 10.1016/j.idc.2018.04.010
3
Che-Pin Chang, Yuan-Chih Su, Mei-Chen Lin, Sheng-Teng Huang. Chinese Herbal Medicine Ameliorated the Development of Chronic Kidney Disease in Patients with Chronic Hepatitis C: A Retrospective Population-Based Cohort StudyEvidence-Based Complementary and Alternative Medicine 2019; 2019: 1 doi: 10.1155/2019/5319456
4
Ruzica Lukic, Nevena Gajovic, Ivan Jovanovic, Milena Jurisevic, Zeljko Mijailovic, Veljko Maric, Biljana Popovska Jovicic, Nebojsa Arsenijevic. Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease PatientsDisease Markers 2017; 2017: 1 doi: 10.1155/2017/6275987
5
Marco Ladino, Fernando Pedraza, David Roth. Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney diseaseWorld Journal of Hepatology 2017; 9(19): 833-839 doi: 10.4254/wjh.v9.i19.833
6
Elena Laura Iliescu, Adriana Mercan-Stanciu, Letitia Toma. Safety and efficacy of direct-acting antivirals for chronic hepatitis C in patients with chronic kidney diseaseBMC Nephrology 2020; 21(1) doi: 10.1186/s12882-020-1687-1
7
Rashmi K S, Faiza Samreen, Anjana Gopi, Swati Jain. SEROPREVALENCE OF HCV INFECTION AMONG PATIENTS IN A TERTIARY CARE HOSPITAL IN BANGALOREJournal of Evolution of Medical and Dental Sciences 2017; 6(31): 2541 doi: 10.14260/Jemds/2017/550
8
Engy A. Mogahed, Hanan Abdelaziz, Heba Helmy, Haytham Ghita, Mohamed A. Abdel Mawla, Fetouh Hassanin, Fatina I. Fadel, Hanaa El-Karaksy. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on HemodialysisJournal of Interferon & Cytokine Research 2016; 36(12): 681 doi: 10.1089/jir.2016.0019
9
Livia Melo Villar, Helena Medina Cruz, Moyra Machado Portilho, Jakeline Ribeiro Barbosa, Ana Carolina Fonseca da Mendonça, Geane Lopes Flores. Public Health - Emerging and Re-emerging Issues2018;  doi: 10.5772/intechopen.79174
10
Karl Lewalter, Sebastian Lemmen. Praktische Krankenhaushygiene und Umweltschutz2016; : 1 doi: 10.1007/978-3-642-41169-4_28-1
11
Nikolaos Papadopoulos, Ioannis Griveas, Eirini Sveroni, Vasiliki Argiana, Antonios Kalliaropoulos, Beatriz Martinez-Gonzalez, Melanie Deutsch. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test?The International Journal of Artificial Organs 2018; 41(3): 168 doi: 10.1177/0391398817752326
12
Ryoichi Miyazaki, Kyoko Miyagi, Rika Kawamura. Treatment of hepatitis C virus infections in hemodialysis patients at our hospital and future prospectsNihon Toseki Igakkai Zasshi 2017; 50(5): 281 doi: 10.4009/jsdt.50.281
13
Tatjana Vilibic-Cavlek, Jasmina Kucinar, Bernard Kaic, Maja Vilibic, Nenad Pandak, Ljubo Barbic, Vladimir Stevanovic, Jasmina Vranes. Epidemiology of hepatitis C in Croatia in the European contextWorld Journal of Gastroenterology 2015; 21(32): 9476-9493 doi: 10.3748/wjg.v21.i32.9476
14
Gaofeng Cai, Hongjie Zheng, Lan Luo, Zhengting Wang, Zhenggang Jiang, Shuangfei Xu, Huakun Lv, Yongdi Chen, Biao Zhou, Chonggao Hu. Factors Correlating to the Development of Hepatitis C Virus Infection in Hemodialysis Patients—Findings Mainly from Asiatic Populations: A Systematic Review and Meta-AnalysisInternational Journal of Environmental Research and Public Health 2019; 16(8): 1453 doi: 10.3390/ijerph16081453
15
Karl Lewalter, Sebastian Lemmen. Praktische Krankenhaushygiene und Umweltschutz2018; : 421 doi: 10.1007/978-3-642-40600-3_28
16
S. Mhalla, R. Hammoud, A. Frih, Y. Kadri, A. El Argoubi, M. Elmay, M. Mastouri. Prevalence and risk factors of hepatitis B and C among hemodialysis patients in TunisiaMédecine et Maladies Infectieuses 2018; 48(3): 175 doi: 10.1016/j.medmal.2017.11.006
17
K. Lewalter, S. Lemmen. Repetitorium Krankenhaushygiene, hygienebeauftragter Arzt und ABS-beauftragter Arzt2017; : 499 doi: 10.1007/978-3-662-54000-8_26
18
L. S. Aho-Glélé, H. Giraudon, K. Astruc, Z. Soltani, A. Lefebvre, P. Pothier, J. B. Bour, C. Manoha. Investigation of a Case of Genotype 5a Hepatitis C Virus Transmission in a French Hemodialysis Unit Using Epidemiologic Data and Deep SequencingInfection Control & Hospital Epidemiology 2016; 37(2): 134 doi: 10.1017/ice.2015.263
19
Javier A. Pagan, Marco Ladino, David Roth. End-Stage Renal Disease and Treatment of Hepatitis C Virus InfectionCurrent Hepatology Reports 2018; 17(1): 78 doi: 10.1007/s11901-018-0387-9
20
Adriana Dejman, Marco A. Ladino, David Roth. Treatment and management options for the hepatitis C virus infected kidney transplant candidateHemodialysis International 2018; 22: S36 doi: 10.1111/hdi.12646
21
Claudia Cottone, Kalyan Ram Bhamidimarri. Evaluating CKD/ESRD patient with hepatitis C infection: How to interpret diagnostic testing and assess liver injurySeminars in Dialysis 2019; 32(2): 119 doi: 10.1111/sdi.12760
22
Ryoichi Miyazaki, Kyoko Miyagi. Effect and Safety of Daclatasvir-Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b -Infected Patients on HemodialysisTherapeutic Apheresis and Dialysis 2016; 20(5): 462 doi: 10.1111/1744-9987.12407
23
Anna Maruyama, Nilufar Partovi, Eric M. Yoshida, Siegfried R. Erb, Vladimir Marquez Azalgara, Trana Hussaini. A review of direct-acting antivirals for the treatment of hepatitis C in patients with advanced chronic kidney diseaseNephrology Dialysis Transplantation 2015; : gfv361 doi: 10.1093/ndt/gfv361
24
A. Ferreira-Gonzalez. Diagnostic Molecular Pathology2017; : 485 doi: 10.1016/B978-0-12-800886-7.00038-8
25
Bengu Tatar, Sukran Kose, Emel Pala, Erhan Tatar. Inflammatory Biomarkers and Liver Histopathology in Non-Uremic and Uremic Chronic Hepatitis C PatientsActa Medica (Hradec Kralove, Czech Republic) 2017; 60(2): 71 doi: 10.14712/18059694.2017.96
26
Jakeline Ribeiro Barbosa, Vanessa Faria Cortes, Moyra Machado Portilho, Juliana Custódio Miguel, Vanessa Alves Marques, Cristianne Sousa Bezerra, Natalia Vasconcelos de Souza, Danielle Malta Lima, Jeová Keny Baima Colares, Lia Laura Lewis-Ximenez, Elisabeth Lampe, Livia Melo Villar. Performance of point of care assays for hepatitis B and C viruses in chronic kidney disease patientsJournal of Clinical Pathology 2018; 71(10): 879 doi: 10.1136/jclinpath-2018-205024
27
Ali Kargar Kheirabad, Fahime Bahri, Mohammad Kargar, Iman Ghasemzadeh. Hepatitis C and G Virus Infection Prevalence Among Hemodialysis Patients and Associated Risk Factors in the Hormozgan Province of Southern IranHepatitis Monthly 2016; 16(10) doi: 10.5812/hepatmon.40375
28
Marco Ladino, Fernando Pedraza, David Roth. Hepatitis C Virus Infection in Chronic Kidney DiseaseJournal of the American Society of Nephrology 2016; 27(8): 2238 doi: 10.1681/ASN.2016010030
29
Kalyan Ram Bhamidimarri, Paul Martin. Finally, safe and effective treatment options for hepatitis C in hemodialysis patientsJournal of Hepatology 2016; 65(1): 7 doi: 10.1016/j.jhep.2016.04.003
30
Sammy Saab, Melissa A. Jimenez, Sherona N. Bau, Gina Choi, Francisco A. Durazo, Mohammed M. El-Kabany, Steven-Huy B. Han, Ronald W. Busuttil. Use of Sofosbuvir-Based Treatment of Chronic Hepatitis C in Liver Transplant Recipients on HemodialysisJournal of Clinical Gastroenterology 2017; 51(2): 167 doi: 10.1097/MCG.0000000000000640
31
Matías J. Pereson, Alfredo P. Martínez, Katia Isaac, Gustavo Laham, Ezequiel Ridruejo, Gabriel H. Garcia, Diego M. Flichman, Federico A. Di Lello. Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina Journal of Medical Microbiology 2021; 70(1) doi: 10.1099/jmm.0.001278
32
Haruki Uojima, Shuzo Kobayashi, Hisashi Hidaka, Shuichi Matsumoto, Takayasu Ohtake, Takeshi Kinbara, Machiko Oka, Yasuhiro Yamanouchi, Takehiko Kunieda, Hiroki Yamanoue, Takayuki Kanemaru, Kazuhiko Tsutsumi, Tomoaki Fujikawa, Ji Hyun Sung, Makoto Kako. Virological response to daclatasvir and asunaprevir combination therapy for chronic hepatitis C virus genotype 1b infection in dialysis patients: a prospective, multicenter studyRenal Replacement Therapy 2017; 3(1) doi: 10.1186/s41100-016-0091-6
33
Aude Desnoyer, Dan Pospai, Minh Patrick Lê, Anne Gervais, Alexandra Heurgué-Berlot, Achour Laradi, Stanislas Harent, Adriana Pinto, Dominique Salmon, Sophie Hillaire, Hélène Fontaine, David Zucman, Anne-Marie Simonpoli, Patrice Muret, Lucile Larrouy, Brigitte Bernard Chabert, Diane Descamps, Yazdan Yazdanpanah, Gilles Peytavin. Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis CJournal of Hepatology 2016; 65(1): 40 doi: 10.1016/j.jhep.2016.02.044
34
Natasha Silva Constancio, Maria Lucia Gomes Ferraz, Carmen Tzanno Branco Martins, Angiolina Campos Kraychete, Paulo Lisboa Bitencourt, Marcelo Mazza do Nascimento. Hepatitis C in Hemodialysis Units: diagnosis and therapeutic approachBrazilian Journal of Nephrology 2019; 41(4): 539 doi: 10.1590/2175-8239-jbn-2018-0177
35
Cristina Gómez-Gutiérrez, Norberto C. Chávez-Tapia, Guadalupe Ponciano-Rodríguez, Misael Uribe, Nahum Méndez-Sánchez. Prevalence of hepatitis C virus infection among patients undergoing haemodialysis in Latin AmericaAnnals of Hepatology 2015; 14(6): 807 doi: 10.5604/16652681.1171751
36
Rita C.F. Tavares, Ana C.C.A. Feldner, João R.R. Pinho, Silvia N.O. Uehara, Christini T. Emori, Roberto J. Carvalho-Filho, Ivonete S.S. Silva, Rúbia A.F. Santana, Vanessa F.D. de Castro, Gregório T. F. Castoli, Charliana U. Cristovão, Maria L.C.G. Ferraz. Prevalence of naturally occurring protease inhibitor resistance-associated variants in hemodialysis and renal transplant patients with hepatitis C virus infectionEuropean Journal of Gastroenterology & Hepatology 2017; 29(7): 754 doi: 10.1097/MEG.0000000000000866